Form 6-K GENETIC TECHNOLOGIES For: Dec 06
FORM 6-K
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
dated December 6, 2016
Commission File Number 0-51504
GENETIC TECHNOLOGIES LIMITED
(Exact Name as Specified in its Charter)
N/A
(Translation of Registrants Name)
60-66 Hanover Street
Fitzroy
Victoria 3065 Australia
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes o No x
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): Not applicable.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused the Report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: December 6, 2016
|
GENETIC TECHNOLOGIES LIMITED | ||
|
| ||
|
| ||
|
By: |
/s/ Kevin Fischer | |
|
|
Name: |
Kevin Fischer |
|
|
Title: |
Company Secretary |
This report on Form 6-K is incorporated by reference in the Registration Statement on Form F-3 of Genetic Technologies Limited (No. 333-210965) filed with the U.S. Securities and Exchange Commission (SEC) on May 17, 2016, and shall be deemed to be a part thereof from the date on which this report is furnished to the SEC, to the extent not superseded by documents or reports subsequently filed or furnished. It contains as exhibits the following documents:
EXHIBIT INDEX
Exhibit |
|
Description of Exhibit |
|
|
|
5.2 |
|
Opinion of K&L Gates LLP |
|
|
|
23.2 |
|
Consent of K&L Gates LLP (filed herewith and included in Exhibit 5.2) |
Exhibit 5.2
Our reference
MILLERN.GAFFNEA.7377758.00031
6 December 2016
The Directors
Genetic Technologies Limited
PO Box 115
FITZROY VIC 3065
Dear Directors
Prospectus Supplement to Form F-3 Registration Statement
We have acted as Australian legal counsel for Genetic Technologies Limited ACN 009 212 328, a company incorporated under the laws of the Commonwealth of Australia (Company), in connection with its filing of:
(a) a registration statement on Form F-3 (Registration Statement) under the Securities Act of 1933 (USA), as amended (the Act) with the Securities and Exchange Commission (the SEC); and
(b) the Prospectus Supplement dated 5 December 2016 (the Prospectus Supplement), of the Company filed with the SEC relating to the issuance by the Company of 720,000,000 ordinary shares without par value (Shares) represented by 4,800,000 American Depositary Shares (as evidenced by American Depositary Receipts (ADR), each ADR representing 150 Shares) (ADS).
Assumptions in providing our opinion
As to various questions of fact relevant to this opinion, we have relied on and assumed the accuracy of, without independent verification:
· an online search of the Company on the Australian Securities and Investments Commission (ASIC) records dated December 5, 2016.
We have relied conclusively on a copy of the Companys Constitution as provided to us by the Company. For the purpose of the opinions set out below, we have also assumed, with your agreement and without independent investigation or verification, that:
(a) the genuineness of all signatures and the authenticity of all documents, instruments and certificates submitted to us as originals and the exact conformity with the authentic originals of all documents, instruments and certificates submitted to us as copies or forms or originals;
(b) that each party to each document has all the requisite power and authority (corporate and otherwise) to execute and deliver and perform its obligations there under;
(c) all matters of internal management required by the constitution of each of the parties to the relevant documents have been duly attended to (including, without limitation, the holding of properly constituted meetings of the boards of directors of each of those parties and the passing at those meetings of appropriate resolutions);
(d) that any documents which purport to be governed by the law of any jurisdiction other than the laws of the Commonwealth of Australia are legal, valid and binding obligations on all of the parties thereto and under the applicable law and that none of the execution, delivery or performance of any document by any party thereto violates or contravenes or is rendered invalid, not binding or unenforceable under any applicable law under any jurisdiction other than the laws of the Commonwealth of Australia;
GPO Box 4388 |
|
Level 25 South Tower |
|
Partner |
(e) no party has contravened or will contravene any provision of the Australian Corporations Act 2001 (including Chapter 2E or Chapter 2J or Chapter 6) (Corporations Act) by entering into the Registration Statement or giving effect to a transaction in connection with the Registration Statement or undertaking or being involved in a transaction related to or connected with the Registration Statement;
(f) the Company will not engage in fraudulent or unconscionable conduct or conduct which is misleading or deceptive or which is likely to mislead or deceive in relation to the issuance or sale of Shares or ADS;
(g) there is no bad faith, fraud, undue influence, coercion or duress or similar conduct on the part of the Company in relation to the issuance or sale of Shares or ADS;
(h) all information provided to us by or on behalf of officers of the Company was true, correct and complete when provided and remains so at the date of this letter, containing all information required, without us making any separate enquiry or investigation other than viewing the ASIC search (see below), in order for us to provide this opinion;
(i) the Company will at all times duly comply with all its obligations under the Corporations Act, the ASX Listing Rules and otherwise required by law, including the lodgment of an Appendix 3B and a cleansing notice under Section 708(5)(e) of the Corporations Act upon each issue of securities under the Registration Statement or Prospectus Supplement or otherwise as permitted under Part 6D.2 of the Corporations Act (Cth);
(j) the Company is and will be able to pay its debts as and when they fall due and is otherwise solvent as at the time the Shares or ADS are issued or sold; and
(k) the ASIC online search we have examined is accurate and that the information disclosed by the search conducted by us is true and complete and that such information has not since then been altered and that such search did not fail to disclose any information which had been delivered for registration or filing against the Companys records but which did not appear on the public records at the date of our search.
Opinion
Based on and subject to the foregoing and in reliance thereof, in our opinion, the Shares have been duly authorized and, when issued, will be validly issued, fully paid and non-assessable securities of the Company.
This opinion is limited to the laws of the Commonwealth of Australia and no opinion or representation is given in respect of the application of any foreign laws to the issue of the securities or the contents or generally the compliance of the Registration Statement or the Prospectus Supplement with any applicable US laws.
Applicability
This opinion is given as at the date of this letter and we undertake no obligation to advise you of any changes (including but not limited to any subsequently enacted, published or reported laws, regulations or individual decisions) that may occur or come to our attention after the date of this letter which may affect our opinion.
We consent to incorporation by reference of this opinion in the Registration Statement and to the reference to this firm under the caption Legal Matters in the Prospectus Supplement, and we consent to the filing of this opinion as an exhibit 5.2 to the Companys Report on Form 6-K.
Yours faithfully
/s/ Andrew Gaffney |
|
Andrew Gaffney |
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
- Genetic Technologies (GENE) Announces $2 Million Registered Direct Offering
- Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!